Advertisement

Topics

Novartis raises pressure in Pfizer’s Ibrance with new Kisqali data

06:10 EST 9 Nov 2017 | PMLIVE

Women on Kisqali were found to have a longer PFS than those on hormonal therapy alone

Original Article: Novartis raises pressure in Pfizer’s Ibrance with new Kisqali data

NEXT ARTICLE

More From BioPortfolio on "Novartis raises pressure in Pfizer’s Ibrance with new Kisqali data"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...